It's nice to see something positive. What you highlight is the reason why I took a foolish, impulsive, $15K nibble, followed by a deeper look at the company (i.e. I made the mistake of putting the cart before the horse). Then Creso Pharma made the announcement about bogus corporate advisory service Everblu being granted an extension of service by Creso as well as an increase in the fee percentage Everblu charges, and a sign on bonus of 2,000,000 shares and 8,000,000 options. It turns out Everblu just so happens to be run by one of the co-founders of Creso Pharma!!!!!
Conflict of interest? Corruption? Rort? You bet! I thought Splitit's payout to its CEO was a rort, but it is beyond belief how blatant this rip off is. The sign on bonus is pending shareholder approval, but when did retail shareholders ever care enough to vote? It is a given that this BS insider rort will be approved at the next AGM.
As for the increase in sales in Q4 and the 700% sales growth, these are UNAUDITED figures. Given the Everblu BS, I no longer believe Creso Pharma's unaudited sales claims.
- Forums
- ASX - By Stock
- CPH
- Ann: Re-engagement of Corporate Advisor
Ann: Re-engagement of Corporate Advisor, page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online